Add 2 More Reports For 20% off

Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Autoinjector Market Outlook

The global autoinjector market size was valued at USD 71.58 billion in 2023. The major industry drivers include the increasing developments in autoinjector design, increased investment in the health care industry, increasing government assistance for favourable reimbursements and increase in preference for disposable autoinjectors. The market is anticipated to grow at a CAGR of 19.1% during the forecast period 2024-2032 to reach a value of USD 345.14 billion by 2032.

Global Autoinjector Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Demand for Disposable Autoinjectors to Augment the Global Autoinjector Industry Growth

Based on type, disposable autoinjectors account for a significant market share of the global autoinjector industry. This can be attributed to their ease of use and the presence of a built-in glass syringe, which eliminates the need for patients with limited dexterity or vision impairments to manually load the glass syringe, making the process more comfortable for them.

As a result, an increase in preference for disposable autoinjectors is expected to aid the market growth. Furthermore, the growing prevalence of rheumatoid arthritis is expected to drive the product demand in the forecast period.

The Asia Pacific to Provide Significant Growth Opportunities to the Global Autoinjector Industry

The Asia Pacific region is expected to witness a rapid growth in the forecast period, indicating a significant potential to contribute to the global autoinjector industry growth. Because of the high prevalence of diabetes and growing healthcare expenditures, a number of prominent autoinjector device manufacturers are being attracted to this region, adding to the market growth. These companies are expanding their presence through a variety of means, including creating sales offices and forming alliances with local pharmaceutical companies, which is expected to drive the growth of the Asia Pacific autoinjector industry in the coming years.

Autoinjector: Market Segmentation

An autoinjector is a medical device that consists of a syringe with a spring-loaded needle and a pre-filled drug dose. Autoinjectors are commonly used to avoid anaphylaxis and provide rapid pain relief. Autoinjectors provide a number of advantages, including reducing needle-related anxiety condition, reducing the danger of needle-stick incidents, assuring dose quality consistency, and assisting with increased efficacy.

Global Autoinjector Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By type, the industry is segmented into:

  • Disposable
  • Reusable

The market can be broadly categorised on the basis of its application into:

  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Anaphylaxis
  • Others

The EMR report looks into the regional markets of the product like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Autoinjector Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Prevalence of Anaphylaxis to Bolster the Growth of the Global Autoinjector Industry

The autoinjector industry is expected to grow considerably in the coming years due to the growing anaphylactic cases globally. As the first line of defence, epinephrine is used to treat anaphylaxis. Innovative designs and portable devices such as autoinjectors with two auto injectable doses in one device and epinephrine with improved temperature stability and shelf life are expected to contribute to the market expansion. Furthermore, the market is expected to grow as a result of the increased efforts by key players in product development, such as the creation of autoinjectors with easy, cost-effective, and cutting-edge technology for the treatment of chronic diseases. The government policies for favourable reimbursements as well as the rapid technological advancements, such as dosage monitoring, are other growth drivers for the industry.

Key Industry Players in the Global Autoinjector Market

The report presents a detailed analysis of the following key players in the global autoinjector market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Amgen Inc.
  • Antares Pharma, Inc.
  • Becton, Dickinson and Company
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Application
  • Route of Administration
  • End User
  • Region
Breakup by Type
  • Disposable
  • Reusable
Breakup by Application
  • Rheumatoid Arthritis
  • Multiple Sclerosis
  • Anaphylaxis
  • Others
Breakup by Route of Administration
  • Subcutaneous
  • Intramuscular
Breakup by End User
  • Hospitals
  • Clinics
  • Home Care Settings
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Amgen Inc.
  • Antares Pharma, Inc.
  • BD
  • Amgen
  • Teva Pharmaceutical Industries Ltd
  • Eli Lilly and Company
  • Ypsomed AG
  • Novartis AG
  • Mylan N.V.
  • GlaxoSmithKline plc
  • Johnson & Johnson Services, Inc.
  • Bayer AG
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!

Key Questions Answered in the Report

The global autoinjector market reached a value of USD 71.58 billion in 2023.

The market is anticipated to grow at a CAGR of 19.1% during the forecast period of 2024-2032 to reach a value of USD 345.14 billion by 2032.

The major industry drivers include the increasing developments in autoinjector design, increased investment in the health care industry, increasing government assistance for favourable reimbursements, increase in preference for disposable autoinjectors and growing prevalence of rheumatoid arthritis.

The key industry trends for global autoinjector industry are the growing anaphylactic cases and increased efforts by key players in product development, such as the creation of autoinjectors with easy, cost-effective, and cutting-edge technology for the treatment of chronic diseases.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with Asia Pacific accounting for the significant share in the market.

The significant type of autoinjector available in the industry are disposable and reusable.

The significant segments of the industry on the basis of application are rheumatoid arthritis, multiple sclerosis, and anaphylaxis, among others.

The major players in the industry are Amgen Inc., Antares Pharma, Inc., and Becton, Dickinson and Company, among others.

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,499

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,699

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,599

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,599

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Strategic Solutions for Informed Decision-Making

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

We’re here to help answer any questions about our products and services.

Contact us

Our Offices


Australia

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63-287-899-028, +63-967-048-3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

63 Fiona Drive, Tamworth, NSW

+61-448-061-727

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.

+63-287-899-028, +63-967-048-3306

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84-865-399-124